- $5.38bn
- $8.93bn
- $23.07bn
- 78
- 77
- 67
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16,596 | 10,710 | 17,596 | 25,729 | 23,068 |
Cost of Revenue | |||||
Gross Profit | 1,216 | 1,056 | 1,350 | 1,379 | 1,365 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 16,132 | 10,306 | 16,883 | 25,051 | 22,433 |
Operating Profit | 464 | 404 | 713 | 678 | 635 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 296 | 236 | 554 | 501 | 430 |
Provision for Income Taxes | |||||
Net Income After Taxes | 313 | 212 | 524 | 475 | 394 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 313 | 212 | 524 | 475 | 394 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 235 | 135 | 446 | 397 | 311 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.34 | 1.77 | 5.53 | 4.54 | 3.58 |
Dividends per Share |